RxDoctor Payments Data

John Dowling, PA

Physician Assistant · Pittsfield, MANPI 1801277108

Payments from drug & device makers

$6,432in general payments, 2019–2025

Across 90 payments — averaging $71.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Senseonics, Incorporated$4K
  • Novo Nordisk$415
  • Lilly USA, LLC$399
  • Insulet Corporation$242
  • Medtronic$209
  • AstraZeneca$164
  • plus $762 from 10 others

What the payments were for

  • Speaking & faculty fees$4,24066%
  • Food & beverage$2,12133%
  • Education$120%
  • Gifts$591%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,432 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$59,355
Medicare patients
337
Services billed
992

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide391$412,235
OzempicSemaglutide374$379,058
MounjaroTirzepatide306$323,428
JardianceEmpagliflozin225$238,181
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7189$226,724
FarxigaDapagliflozin Propanediol147$141,342
JanuviaSitagliptin Phosphate82$86,884
TradjentaLinagliptin85$73,989
Fiasp FlextouchInsulin Aspart (Niacinamide)73$59,392
Humulin R U-500Insulin Regular, Human39$57,318
WegovySemaglutide42$56,446
Xultophy 100-3.6Insulin Degludec/Liraglutide32$47,430
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog103$47,211
Bydureon BciseExenatide Microspheres43$42,871
Tresiba Flextouch U-200Insulin Degludec36$41,173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humalog, Baqsimi$399$758,055749 claims
Novo NordiskOzempic, Wegovy, Xultophy 100-3.6, Fiasp, Novolog$415$542,018536 claims
Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Trijardy Xr$22$373,002374 claims
AstraZenecaFarxiga$164$141,342147 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$131$27,65848 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Pittsfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →